Behnam Moein Jahromi, MD
Gastroenterology · Oceanside, CANPI 1255788329
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.2% of the total across 151 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 26 manufacturers reported payments, led by AbbVie at 41.4% of the total.
Across 151 payments — averaging $27.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Johnson & Johnson$336
- Pfizer$315
- Takeda Pharmaceuticals U.S.A., Inc.$261
- Ferring Pharmaceuticals Inc.$248
- Sanofi$218
- plus $1K from 20 others
Across 7 payments — averaging $4815.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Ferring Pharmaceuticals AS$34K
What the payments were for
- Food & beverage$4,07998%
- Education$762%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 59 | $1,721 |
| Johnson & Johnson | 17 | $336 |
| Pfizer | 14 | $315 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $261 |
| Ferring Pharmaceuticals Inc. | 4 | $248 |
| Sanofi | 4 | $218 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 10 | $183 |
| Aimmune Therapeutics, Inc. | 1 | $125 |
| E.r. Squibb & Sons, L.L.C. | 1 | $123 |
| Vivus LLC | 5 | $106 |
| Lilly USA, LLC | 3 | $97 |
| Merck | 5 | $78 |
| QOL Medical, LLC | 3 | $54 |
| Intercept Pharmaceuticals, Inc. | 3 | $53 |
| UCB, Inc. | 1 | $34 |
| Regeneron Healthcare Solutions, Inc. | 1 | $27 |
| Irhythm Technologies, Inc. | 1 | $23 |
| Alnylam Pharmaceuticals Inc. | 1 | $22 |
| Alfasigma USA, Inc. | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Daiichi Sankyo Inc. | 1 | $18 |
| Phathom Pharmaceuticals, Inc. | 1 | $18 |
| Eisai Inc. | 1 | $16 |
| Exact Sciences | 1 | $14 |
| Shionogi Inc | 1 | $14 |
| Ironwood Pharmaceuticals, Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,155 in reported general payments places this provider in the 60th percentile of 1,885 gastroenterology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 99 | $6,375 |
| Esomeprazole Magnesium | 54 | $1,013 |
| Pantoprazole Sodium | 76 | $933 |
| Entecavir | 14 | $660 |
| Omeprazole | 59 | $631 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 43 | $508 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 16 | $224 |
| Famotidine | 12 | $149 |
| Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl | 11 | $135 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Oceanside
- Mazer AllyOceanside$229K
- Bennett RothLos Angeles$2.8M
- Douglas NguyenMission Viejo$2M
- Sammy SaabLos Angeles$1.9M
- Kenneth ChangNewport Beach$1.3M
- Joo HwangStanford$1M
- Drew SchembreWalnut Creek$659K
- Quan Nhula Jolla$641K
- Sadeea AbbasiLos Angeles$556K
- Ali RezaieWest Hollywood$519K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.